Epilepsy in Sturge-Weber syndrome: a literature review and description of a clinical case
https://doi.org/10.17749/2077-8333.2020.12.1.67-73
Abstract
The Struge-Weber syndrome is the third most common neurodermal disease after neurofibromatosis and tuberous sclerosis. This disease is not inherited, but occurs exclusively sporadically, both in men and in women, and in all races and ethnic groups. In 90% of cases, this syndrome is diagnosed in pediatric practice. Adult cases of this syndrome are sporadic, since they remain unrecognized due to the polymorphism of this disease. Comorbidity between epilepsy and the Sturge-Weber syndrome was noted.
Aim. To conduct a literature analysis and describe the clinical observation of epilepsy with the Sturge-Weber syndrome.
Materials and methods. Patient M., 50 years old has been observed for a long time due to complaints on episodes of numbness according to the hematotype with transient paresis. The examination (MRI) revealed changes characteristic for Sturge-Weber syndrome. The presence of specific paroxysmal changes according to the results of electroencephalography helped to verify the genesis of paroxysmal conditions.
Results. The patient underwent a comprehensive examination. As a result, the diagnosis of epilepsy was verified. The prescription of adequate antiepileptic therapy allowed for stabilization and jugulation of epileptic seizures.
Conclusion. In this clinical observation, we focus on the differential diagnosis between transient ischemic attack and epilepsy. Unfortunately, at the moment, adults with a previously undetectable syndrome undergo multiple hospitalizations and do not receive antiepileptic therapy, since the prior disease (epilepsy) is not verified.
About the Authors
N. I. ShovaRussian Federation
graduate student,
3 Bekhtereva Str., Saint Petersburg 192019, Russia
V. A. Mikhailov
Russian Federation
MD, Dr Sci Med, Vice-director for innovative scientific development and international cooperation, Head of the international department, Chief researcher and Scientific director of the Department for the treatment of organic mental disorders and epilepsy and rehabilitation of patients with psychosomatic disorders,
3 Bekhtereva Str., Saint Petersburg 192019, Russia
S. A. Korovina
Russian Federation
MD, PhD, Head of the Department for the treatment of organic mental disorders/epilepsy,
3 Bekhtereva Str., Saint Petersburg 192019, Russia
D. V. Alekseeva
Russian Federation
Junior Researcher, 7th Department,
3 Bekhtereva Str., Saint Petersburg 192019, Russia
References
1. Comi A.M. Sturge-Weber syndrome. Handb Clin Neurol. 2015;132:157–68.
2. Shirley M.D., Tang H., Gallione C.J., Baugher J.D., Frelin L.P., Cohen B., North P.E., Marchuk D.A., Comi A.M., Pevsner J. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N. Engl. J. Med. 2013;368(21):9–1971.
3. Pinto A., Sahin M., Pearl P.L., Epileptogenesis in neurocutaneous disorders with focus in Sturge Weber syndrome. F1000Res. 2016;5.
4. Jagtap S., Srinivas G., Harsha K.J., Radhakrishnan N., Radhakrishnan A. Sturge-Weber syndrome: clinical spectrum, disease course, and outcome of 30 patients. J Child Neurol. 2013;28(6):31–725.
5. Kossoff E.H., Ferenc L., Comi A.M. An infantile-onset, severe, yet sporadic seizure pattern is common in Sturge-Weber syndrome. Epilepsia. 2009;50(9):2154–7.
6. Pinto A., Sahin M., Pearl P.L. Epileptogenesis in neurocutaneous disorders with focus in Sturge-Weber syndrome. F1000Res. (2016) 5:370.10.12688/f1000research.7605.1
7. Iimura Y., Sugano H., Nakajima M., Higo T., Suzuki H., Nakanishi H. Analysis of epileptic discharges from implanted subdural electrodes in patients with Sturge–Weber syndrome. PLoS One. 2016;11(4):e0152992.
8. Alkonyi B., Chugani H.T., Juhasz C. Transient focal cortical increase of interictal glucose metabolism in Sturge–Weber syndrome: implications for epileptogenesis. Epilepsia. 2011;52(7):72-1265.
9. Comi A.M, Sahin M., Hammill A., Kaplan E.H., Juhasz C., North P. Leveraging a Sturge–Weber gene discovery: an agenda for future research. Pediatr Neurol. 2016;58:12–24.
10. Enjolras O., Riche M.C., Merland J.J. Facial port-wine stains and Sturge-Weber syndrome. Pediatrics. 1985;76(1):48-51.
11. Marana Perez A.I., Ruiz-Falco Rojas M.L., Puertas Martin V., Dominguez Carral J., Carreras Saez I., Duat Rodriguez A., Sanchez Gonzalez V. Analysis of Sturge-Weber syndrome: A retrospective study of multiple associated variables. Neurologia. 2017;32(6):363-370.
12. Comi A.M. Update on Sturge-Weber syndrome: diagnosis, treatment, quantitative measures, and controversies. Lymphat Res Biol. 2007;5(4):64-257.
13. Kaplan E.H., Kossoff E.H., Bachur C.D., Gholston M., Hahn J., Widlus M., et al. Anticonvulsant efficacy in Sturge–Weber syndrome. Pediatr Neurol. 2016;58:31–6.
14. Rapoport Y., Benegas N., Kuchtey R.W., Joos K.M. Acute myopia and angle closure glaucoma from topiramate in a seven-year-old: a case report and review of the literature. BMC Pediatr. 2014;14:96.
15. Kossoff E.H., Borsage J.L., Comi AM. A pilot study of the modified Atkins diet for Sturge–Weber syndrome. Epilepsy Res. 2010;92(2):240–3.
16. Arzimanoglou A.A., Andermann F., Aicardi J., Sainte-Rose C., Beaulieu M.A., Villemure J.G., Olivier A., Rasmussen T. Sturge- Weber syndrome: indications and results of surgery in 20 patients. Neurology. 2000;55(10):9-1472.
17. Bay M.J., Kossoff E.H., Lehmann C.U., Zabel T.A., Comi A.M. Survey of aspirin use in Sturge-Weber syndrome. J. Child Neurol. 2011;26(6):692-702.
18. Higueros E., Roe E., Granell E., Baselga E. Sturge-Weber Syndrome: A Review. Actas Dermosifiliogr. 2017;108(5):407-417.
Review
For citations:
Shova N.I., Mikhailov V.A., Korovina S.A., Alekseeva D.V. Epilepsy in Sturge-Weber syndrome: a literature review and description of a clinical case. Epilepsy and paroxysmal conditions. 2020;12(1):67-73. (In Russ.) https://doi.org/10.17749/2077-8333.2020.12.1.67-73

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.